Pfizer (NYSE:PFE) may be about to take a major step forward in its coronavirus vaccine development efforts.
"We are very close to submitting for an emergency use authorization," CEO Albert Bourla said during the STAT Summit on Tuesday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,